SB681323

DRUG3 trials

Sponsors

GlaxoSmithKline

Conditions

Chronic Obstructive Pulmonary Disease (COPD)Pain, NeuropathicPulmonary Disease, Chronic Obstructive

Phase 1

Study of SB681323 and Prednisolone on Biomarkers in COPD (Chronic Obstructive Pulmonary Disease) Patients

CompletedNCT00380133

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2005-06-30End: 2006-04-30Updated: 2012-06-04

Phase 2

Safety And Anti-Inflammatory Effect Of SB681323 In Patients With Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT00144859

GlaxoSmithKlineChronic Obstructive Pulmonary Disease (COPD), Pulmonary Disease, Chronic Obstructive

Start: 2005-07-31Target: 82Updated: 2012-06-04

P38 Mitogen-activated Protein (Map) Kinase Inhibitor (SB-681323)Study In Patients With Neuropathic Pain

CompletedNCT00390845

GlaxoSmithKlinePain, Neuropathic

Start: 2006-08-30End: 2008-08-11Updated: 2017-08-22